Compare STKL & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STKL | NPCE |
|---|---|---|
| Founded | 1973 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 769.4M | 432.3M |
| IPO Year | 1999 | 2021 |
| Metric | STKL | NPCE |
|---|---|---|
| Price | $6.49 | $15.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $7.50 | ★ $18.33 |
| AVG Volume (30 Days) | ★ 1.2M | 166.5K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 186.67 | 29.03 |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $817,715,000.00 | $99,986,000.00 |
| Revenue This Year | $6.84 | $0.90 |
| Revenue Next Year | $33.58 | $24.46 |
| P/E Ratio | $49.88 | ★ N/A |
| Revenue Growth | 12.99 | ★ 25.13 |
| 52 Week Low | $3.32 | $7.56 |
| 52 Week High | $6.94 | $18.97 |
| Indicator | STKL | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 69.73 | 63.50 |
| Support Level | $6.43 | $15.25 |
| Resistance Level | $6.52 | $15.71 |
| Average True Range (ATR) | 0.02 | 0.66 |
| MACD | -0.02 | 0.22 |
| Stochastic Oscillator | 58.33 | 94.37 |
SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own proprietary brands, including SOWN, Dream, and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut, and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada, and Others, out of which it derives maximum revenue from U.S.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.